BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Amexdrug Corp. (AXRX) Reports Growth and Profitability in Second Quarter 2009


9/8/2009 11:08:15 AM

BEVERLY HILLS, CA--(Marketwire - September 08, 2009) - AmexDrug Corporation (OTCBB: AXRX), a vertically integrated pharmaceutical and cosmeceutical company, today announced second quarter 2009 financial results.

"Our second quarter and months earlier this year showcase the most significant developments since the company's inception," said Jack Amin, President and CEO of AmexDrug Corp.

Second Quarter 2009 Highlights:

-- Revenues increased 65.7% year-over-year to a record of $2.43 million.

-- Gross profit increased $256,928, compared to the second quarter of 2008, representing a gross margin increase of 209.3%.

-- Costs of Goods Sold increased 57.1% year-over-year to a record of $2.17 million.

-- Expenses increased 22.0% year-to-year to a record of $115,493.

-- Net income was up to $79,159, a significant increase from the prior year largely attributed to the increase in sales.

"AmexDrug Corporation is expanding. Our profits are increasing. And our cultivated company culture is attracting the best talent in the country," said Amin. "With our latest expansion into Asia Pacific, our affiliated network offices are fine-tuned and expected to increase revenues moving into 2010."

About AmexDrug Corporation (OTCBB: AXRX):

AmexDrug Corp. is a vertically integrated pharmaceutical and cosmeceutical company. With its subsidiaries BioRx Pharmaceuticals, Dermagen, Inc., and Allied Med, Inc., AmexDrug Corp. develops, manufactures, markets, and distributes private-label over-the-counter pharmaceuticals, innovative skin care products and prescription packaging to the nation's largest wholesalers and distributors. In addition, the company distributes prescription drugs to independent pharmacies. AmexDrug Corp. has an experienced executive team, advanced manufacturing facility and broad distribution network, allowing the company to integrate various phases of operations into one efficient business entity. For more information about AmexDrug Corp., please visit www.amexdrug.com.

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, economic conditions in the industry and the financial strength of the company's customers and suppliers. The company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.


AmexDrug Corp.
Jack Amin
(310) 855-0475
jack.amin@amexdrug.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES